Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06865417
What this trial is testing

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Alfasigma S.p.A. 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT05976802
What this trial is testing

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT05291689
What this trial is testing

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

Who this might be right for
Inflammatory Bowel DiseasesColitis, Ulcerative
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 39
Testing effectiveness (Phase 2)Study completedNCT00303381
What this trial is testing

Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
EMD Serono 194
Testing effectiveness (Phase 2)Ended earlyNCT04987307
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 221
Testing effectiveness (Phase 2)UnknownNCT01039597
What this trial is testing

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Who this might be right for
Mild to Moderate Ulcerative Colitis
Ore Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07470879
What this trial is testing

How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Pfizer 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755241
What this trial is testing

AC-101 Tablets in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Accro Bioscience (Suzhou) Limited 153
Not applicableLooking for participantsNCT07389824
What this trial is testing

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Qin Yu 66
Large-scale testing (Phase 3)Ended earlyNCT04985968
What this trial is testing

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 171
Testing effectiveness (Phase 2)Ended earlyNCT01375179
What this trial is testing

Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Study completedNCT03123120
What this trial is testing

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 22
Large-scale testing (Phase 3)Study completedNCT03482635
What this trial is testing

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242484
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 577
Large-scale testing (Phase 3)Study completedNCT02136069
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 397
Early research (Phase 1)Study completedNCT05975047
What this trial is testing

LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Liveome Inc. 38
Testing effectiveness (Phase 2)Study completedNCT04504383
What this trial is testing

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
Protagonist Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Ended earlyNCT06137183
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 79
Early research (Phase 1)UnknownNCT01697670
What this trial is testing

Photodynamic Therapy for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Zurich 7
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation